Glaucome IV: EDI, recherche et innovations
Mon statut pour la session
À la fin de cette séance, les participants seront en mesure de faire ce qui suit:
- Discuter des questions d’EDI pour les soins cliniques et la recherche dans le domaine du glaucome.
- Discuter de sujets de recherche de pointe dans le domaine du glaucome.
- Décrire l’histoire et l’évolution de la recherche dans le domaine du glaucome.
CanMEDS : Promoteur de la santé, Érudit
Sous sessions
Author’s Name(s): Charley Cai, Hoyoung Jung, Yudan Chen, Tiffany Tse, Jiwon Hwang, Myeong Jin Ju, Zaid MammoAuthor’s Disclosure Block: Charley Cai, none; Hoyoung Jung, none; Yudan Chen, none; Tiffany Tse, none; Jiwon Hwang, none; Myeong Jin Ju, none; Zaid Mammo, noneAbstract BodyPurpose:The vascular theory of glaucoma posits that dysregulated ocular blood flow leads to ischemic optic nerve damage. We compare a novel voxel-ba...
Author’s Name(s): Tianwei Ellen Zhou, David Mathew, Karen Wigg, Carmen Balian, Irfan Kherani, Matthew Schlenker, Jeremy SivakAuthor’s Disclosure Block: Tianwei Ellen Zhou, none; David Mathew, none; Karen Wigg, none; Carmen Balian, none; Irfan Kherani, none; Matthew Schlenker, none; Jeremy Sivak, noneAbstract BodyPurpose: Primary open-angle glaucoma (POAG) makes up 90% of glaucoma cases in developed countries and is associate...
Author’s Name(s): Kate Lim, Hoyoung Jung, Korolos Sawires, Bonnie He, Brennan Eadie, Edsel IngAuthor’s Disclosure Block: Kate Lim, none; Hoyoung Jung, none; Korolos Sawires, none; Bonnie He, none; Brennan Eadie, none; Edsel Ing, noneAbstract BodyPurpose:Various case reports and studies based on adverse drug event reporting systems have explored a potential association between topiramate therapy and the onset of glaucoma. How...
Author’s Name(s): Bonnie He, Mahyar Etminan, Brennan EadieAuthor’s Disclosure Block: Bonnie He, none; Mahyar Etminan, none ; Brennan Eadie, noneAbstract BodyPurpose:Calcium channel blockers (CCBs) are one of the most prescribed agents for cardiovascular disease (CVD) globally and are frequently used as first line agents in treating hypertension. Recent epidemiologic studies have shown an adverse relationship between CCBs use...
Author’s Name(s): Raheem Remtulla, Guillermo RochaAuthor’s Disclosure Block: Raheem Remtulla, none; Guillermo Rocha, noneAbstract BodyPurpose: Visual field (VF) testing is crucial in monitoring glaucoma patients, providing key insights for clinical management. However, the process is often hindered by technician shortages and reliability issues. While attempts to reduce technician dependency have been explored, little effort...
Author’s Name(s): Sohat Sharma, Rishav Singh, Michael Balas, David MathewAuthor’s Disclosure Block: Sohat Sharma, none; Rishav Singh, none; Michael Balas, none; David Mathew, noneAbstract BodyPurpose: This systematic review and meta-analysis aimed to assess the safety and efficacy of Omidenpag Isopropyl (OMDI) 0.002% in comparison to commonly used Prostaglandin F2alpha receptor (FP) agonists used in glaucoma management. Stud...
Author’s Name(s): James Armstrong, Matthew Fung, Anastasiya Vinokurtseva, Victoria Leung, Richard Zhang, Hong Liu, Cindy HutnikAuthor’s Disclosure Block: James Armstrong, none; Matthew Fung, none; Anastasiya Vinokurtseva, none; Victoria Leung, none; Richard Zhang, none; Hong Liu, none; Cindy Hutnik, noneAbstract BodyPurpose: The success of bleb-forming glaucoma surgery is contingent on the continued diffusion of aqueous thro...